{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T04:04:23Z","timestamp":1751256263543,"version":"3.41.0"},"reference-count":42,"publisher":"Federa\u00e7\u00e3o das Associa\u00e7\u00f5es de Ginecologia e Obstetr\u00edcia","issue":"02","license":[{"start":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T00:00:00Z","timestamp":1515369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev Bras Ginecol Obstet"],"published-print":{"date-parts":[[2018,2]]},"abstract":"<jats:p>Objective\u2003The current study evaluated the expression of WW domain-containing oxidoreductase (WWOX), its association with clinicopathological features and with p53, Ki-67 (cell proliferation) and CD31 (angiogenesis) expression in patients with invasive cervical squamous cell carcinoma (ICSCC). To the best of our knowledge, no other study has evaluated this association.<\/jats:p><jats:p>Methods\u2003Women with IB stage-ICSCC (n\u2009=\u200920) and women with uterine leiomyoma (n\u2009=\u200920) were prospectively evaluated. Patients with ICSCC were submitted to type B-C1 radical hysterectomy and pelvic lymphadenectomy. Patients in the control group underwent vaginal hysterectomy. Tissue samples were stained with hematoxylin and eosin for histological evaluation and protein expression was detected by immunohistochemistry studies.<\/jats:p><jats:p>Results\u2003The WWOX expression was significantly lower in the tumor compared with the expression in the benign cervix (p\u2009=\u20090.019). The WWOX expression was inversely associated with the CD31 expression in the tumor samples (p\u2009=\u20090.018). There was no association between the WWOX expression with the p53 expression (p\u2009=\u20090.464) or the Ki-67 expression (p\u2009=\u20090.360) in the samples of invasive carcinoma of the cervix. There was no association between the WWOX expression and tumor size (p\u2009=\u20090.156), grade of differentiation (p\u2009=\u20090.914), presence of lymphatic vascular invasion (p\u2009=\u20090.155), parametrium involvement (p\u2009=\u20090.421) or pelvic lymph node metastasis (p\u2009=\u20090.310) in ICSCC tissue samples.<\/jats:p><jats:p>Conclusion\u2003The results suggested that WWOX may be involved in ICSCC carcinogenesis, and this marker was associated with tumor angiogenesis.<\/jats:p>","DOI":"10.1055\/s-0037-1618597","type":"journal-article","created":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T23:43:00Z","timestamp":1515454980000},"page":"079-085","source":"Crossref","is-referenced-by-count":6,"title":["Immunohistochemical WWOX Expression and Association with Angiogenesis, p53 Expression, Cell Proliferation and Clinicopathological Parameters in Cervical Cancer"],"prefix":"10.61622","volume":"40","author":[{"given":"Mariana Ataydes Leite","family":"Seabra","sequence":"additional","affiliation":[{"name":"Universidade Federal Minas Gerais, Belo Horizonte, MG, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo Batista","family":"C\u00e2ndido","sequence":"additional","affiliation":[{"name":"Universidade Federal Minas Gerais, Belo Horizonte, MG, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula Vieira Teixeira","family":"Vidigal","sequence":"additional","affiliation":[{"name":"Universidade Federal Minas Gerais, Belo Horizonte, MG, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rivia Mara","family":"Lamaita","sequence":"additional","affiliation":[{"name":"Universidade Federal Minas Gerais, Belo Horizonte, MG, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ang\u00e9lica Nogueira","family":"Rodrigues","sequence":"additional","affiliation":[{"name":"Universidade Federal Minas Gerais, Belo Horizonte, MG, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnaldo Lopes da","family":"Silva Filho","sequence":"additional","affiliation":[{"name":"Universidade Federal Minas Gerais, Belo Horizonte, MG, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"47794","published-online":{"date-parts":[[2018,1,8]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1016\/S0140-6736(03)13778-6","article-title":"Cervical cancer","volume":"361","author":"S E Waggoner","year":"2003","journal-title":"Lancet"},{"issue":"12","key":"ref2","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1002\/ijc.25517","article-title":"Fifty years of cancer incidence: CI5 I-IX","volume":"127","author":"D M Parkin","year":"2010","journal-title":"Int J Cancer"},{"volume-title":"Instituto Nacional de C\u00e2ncer Jos\u00e9 de Alencar Gomes da Silva. Estimativa 2016: Incid\u00eancia de C\u00e2ncer no Brasil","year":"2016","key":"ref3"},{"issue":"06","key":"ref4","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1136\/jcp.33.6.517","article-title":"Progression and regression of cervical lesions. Review of smears from women followed without initial biopsy or treatment","volume":"33","author":"A I Spriggs","year":"1980","journal-title":"J Clin Pathol"},{"issue":"02","key":"ref5","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/ijc.29719","article-title":"Factors associated with type-specific persistence of high-risk human papillomavirus infection: A population-based study","volume":"138","author":"S Stensen","year":"2016","journal-title":"Int J Cancer"},{"issue":"03","key":"ref6","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.ygyno.2004.07.059","article-title":"Expression of p53, Ki-67, and CD31 in the vaginal margins of radical hysterectomy in patients with stage IB carcinoma of the cervix","volume":"95","author":"A L Silva-Filho","year":"2004","journal-title":"Gynecol Oncol"},{"issue":"06","key":"ref7","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1093\/cid\/cix475","article-title":"Age of acquiring causal human papillomavirus (HPV) infections: leveraging simulation models to explore the natural history of HPV-induced cervical cancer","volume":"65","author":"E A Burger","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"01","key":"ref8","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.canlet.2009.07.017","article-title":"Oncosuppressor proteins of fragile sites are reduced in cervical cancer","volume":"289","author":"E Giarnieri","year":"2010","journal-title":"Cancer Lett"},{"issue":"02","key":"ref9","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2174\/1389202917666160803165229","article-title":"Anticancer natural compounds as epigenetic modulators of gene expression","volume":"18","author":"E A Ratovitski","year":"2017","journal-title":"Curr Genomics"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12918-016-0260-9","article-title":"Integrative modeling of multi-omics data to identify cancer drivers and infer patient-specific gene activity","volume":"10","author":"A B Pavel","year":"2016","journal-title":"BMC Syst Biol"},{"issue":"20","key":"ref11","doi-asserted-by":"crossref","first-page":"6107","DOI":"10.1158\/0008-5472.CAN-16-0621","article-title":"WWOX and p53 dysregulation synergize to drive the development of osteosarcoma","volume":"76","author":"S Del Mare","year":"2016","journal-title":"Cancer Res"},{"issue":"09","key":"ref12","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1038\/sj.onc.1208398","article-title":"Fragile genes as biomarkers: epigenetic control of WWOX and FHIT in lung, breast and bladder cancer","volume":"24","author":"D Iliopoulos","year":"2005","journal-title":"Oncogene"},{"issue":"04","key":"ref13","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.ejca.2009.12.021","article-title":"WWOX tumour suppressor gene polymorphisms and ovarian cancer pathology and prognosis","volume":"46","author":"A J Paige","year":"2010","journal-title":"Eur J Cancer"},{"issue":"08","key":"ref14","first-page":"2140","article-title":"WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer","volume":"60","author":"A K Bednarek","year":"2000","journal-title":"Cancer Res"},{"issue":"01","key":"ref15","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5507\/bp.2007.002","article-title":"WWOX, a new potential tumor suppressor gene","volume":"151","author":"R Hezova","year":"2007","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"issue":"07","key":"ref16","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1158\/1078-0432.CCR-03-0096","article-title":"The tumor suppressor gene WWOX at FRA16D is involved in pancreatic carcinogenesis","volume":"10","author":"T Kuroki","year":"2004","journal-title":"Clin Cancer Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1159\/000455753","article-title":"Fragile genes that are frequently altered in cancer: players not passengers","volume":"150","author":"J R Karras","year":"2016","journal-title":"Cytogenet Genome Res"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1471-2407-5-64","article-title":"WWOX protein expression varies among ovarian carcinoma histotypes and correlates with less favorable outcome","volume":"5","author":"M I Nunez","year":"2005","journal-title":"BMC Cancer"},{"issue":"23","key":"ref19","doi-asserted-by":"crossref","first-page":"4601","DOI":"10.1007\/s00018-014-1753-6","article-title":"Very large common fragile site genes and their potential role in cancer development","volume":"71","author":"G Gao","year":"2014","journal-title":"Cell Mol Life Sci"},{"issue":"11","key":"ref20","first-page":"1586","article-title":"[Expressions of WWOX and CD133 in colorectal cancer and their clinical significance]","volume":"35","author":"B Zhu","year":"2015","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"issue":"02","key":"ref21","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2217\/fon.09.152","article-title":"WWOX gene and gene product: tumor suppression through specific protein interactions","volume":"6","author":"Z Salah","year":"2010","journal-title":"Future Oncol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1159\/000072844","article-title":"WWOX, the common chromosomal fragile site, FRA16D, cancer gene","volume":"100","author":"J H Ludes-Meyers","year":"2003","journal-title":"Cytogenet Genome Res"},{"issue":"03","key":"ref23","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1177\/1535370214561590","article-title":"WWOX: a fragile tumor suppressor","volume":"240","author":"M S Schrock","year":"2015","journal-title":"Exp Biol Med (Maywood)"},{"issue":"S 01","key":"ref24","first-page":"47","article-title":"WWOX, the tumour suppressor gene affected in multiple cancers","volume":"60","author":"U Lewandowska","year":"2009","journal-title":"J Physiol Pharmacol"},{"issue":"02","key":"ref25","first-page":"265","article-title":"Five classes of extended hysterectomy for women with cervical cancer","volume":"44","author":"M S Piver","year":"1974","journal-title":"Obstet Gynecol"},{"issue":"07","key":"ref26","first-page":"377","article-title":"Additional data in the technic of vaginal hysterectomy","volume":"56","author":"N S Heaney","year":"1948","journal-title":"West J Surg, Obstet Gynecol"},{"issue":"02","key":"ref27","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0020-7292(00)90001-8","article-title":"FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers","volume":"70","author":"J L Benedet","year":"2000","journal-title":"Int J Gynaecol Obstet"},{"issue":"05","key":"ref28","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1034\/j.1600-0412.1999.780520.x","article-title":"Histopathological factors influencing pelvic lymph node metastases in two or more sites in patients with cervical carcinoma undergoing radical hysterectomy","volume":"78","author":"T Kamura","year":"1999","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"03","key":"ref29","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1177\/1535370214565992","article-title":"WWOX, large common fragile site genes, and cancer","volume":"240","author":"G Gao","year":"2015","journal-title":"Exp Biol Med (Maywood)"},{"issue":"01","key":"ref30","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/00001703-200302000-00007","article-title":"Angiogenesis: prognostic and therapeutic implications in gynecologic and breast malignancies","volume":"15","author":"G Sauer","year":"2003","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"03","key":"ref31","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.ygyno.2008.11.013","article-title":"Markers of angiogenesis in high-risk, early-stage cervical cancer: A Gynecologic Oncology Group study","volume":"112","author":"L M Randall","year":"2009","journal-title":"Gynecol Oncol"},{"issue":"37","key":"ref32","doi-asserted-by":"crossref","first-page":"60917","DOI":"10.18632\/oncotarget.17126","article-title":"Decreased WWOX expression promotes angiogenesis in osteosarcoma","volume":"8","author":"J Wen","year":"2017","journal-title":"Oncotarget"},{"issue":"05","key":"ref33","first-page":"320","article-title":"[Correlation between mutation of p53 gene 2-4 exons from peripheral blood and HPV16 positive cervical cancer susceptibility and clinical significance]","volume":"52","author":"C M Yin","year":"2017","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"issue":"12","key":"ref34","doi-asserted-by":"crossref","first-page":"e6424","DOI":"10.1097\/MD.0000000000006424","article-title":"Clinical effects of p53 overexpression in squamous cell carcinoma of the sinonasal tract: A systematic meta-analysis with PRISMA guidelines","volume":"96","author":"X Wang","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"04","key":"ref35","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/GCO.0b013e3283073ab7","article-title":"The evolutionary state of electrosurgery: where are we now?","volume":"20","author":"A P Advincula","year":"2008","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"04","key":"ref36","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/01.pgp.0000167113.86586.65","article-title":"A Strategy for defining biologically relevant levels of p53 protein expression in clinical samples with reference to endometrial neoplasia","volume":"24","author":"W G McCluggage","year":"2005","journal-title":"Int J Gynecol Pathol"},{"issue":"05","key":"ref37","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/PGP.0b013e31826f5cf6","article-title":"Immunohistochemical expression of cyclin D1, p16Ink4a, p21WAF1, and Ki-67 correlates with the severity of cervical neoplasia","volume":"32","author":"E A Portari","year":"2013","journal-title":"Int J Gynecol Pathol"},{"issue":"S 01","key":"ref38","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s13224-015-0754-1","article-title":"The role of p53 gene in cervical carcinogenesis","volume":"66","author":"P S Garima","year":"2016","journal-title":"J Obstet Gynaecol India"},{"issue":"05","key":"ref39","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.3892\/ol.2017.5901","article-title":"Efficacy of recombinant human adenovirus-p53 combined with chemotherapy for locally advanced cervical cancer: A clinical trial","volume":"13","author":"J Xiao","year":"2017","journal-title":"Oncol Lett"},{"issue":"03","key":"ref40","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1177\/1535370214565990","article-title":"WWOX, the chromosomal fragile site FRA16D spanning gene: its role in metabolism and contribution to cancer","volume":"240","author":"R I Richards","year":"2015","journal-title":"Exp Biol Med (Maywood)"},{"issue":"31","key":"ref41","doi-asserted-by":"crossref","first-page":"49611","DOI":"10.18632\/oncotarget.10417","article-title":"Transcriptome-wide characterization of the endogenous miR-34A-p53 tumor suppressor network","volume":"7","author":"N Samuel","year":"2016","journal-title":"Oncotarget"},{"key":"ref42","first-page":"29","article-title":"Augmenting antitumor immune responses with epigenetic modifying agents","volume":"6","author":"E H\u00e9ninger","year":"2015","journal-title":"Front Immunol"}],"container-title":["Revista Brasileira de Ginecologia e Obstetr\u00edcia \/ RBGO Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journalrbgo.org\/article\/immunohistochemical-wwox-expression-and-association-with-angiogenesis-p53-expression-cell-proliferation-and-clinicopathological-parameters-in-cervical-cancer\/","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0037-1618597.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,29]],"date-time":"2025-06-29T14:11:04Z","timestamp":1751206264000},"score":1,"resource":{"primary":{"URL":"https:\/\/journalrbgo.org\/article\/immunohistochemical-wwox-expression-and-association-with-angiogenesis-p53-expression-cell-proliferation-and-clinicopathological-parameters-in-cervical-cancer\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,8]]},"references-count":42,"journal-issue":{"issue":"02","published-online":{"date-parts":[[2018,2,28]]},"published-print":{"date-parts":[[2018,2]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0037-1618597","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0100-7203","1806-9339"],"issn-type":[{"type":"print","value":"0100-7203"},{"type":"electronic","value":"1806-9339"}],"subject":[],"published":{"date-parts":[[2018,1,8]]}}}